Mitral transcatheter edge-to-edge repair (M-TEER) with the fourth generation MitraClip G4 system was safe and effective at 1 year, with durable reductions in mitral regurgitation (MR) severity in more than 90% of patients and concomitant improvement in functional status and quality of life, according to an ongoing prospective multicenter registry study.